MX354409B - Derivados de estradiol sustituidos en 6 para uso en remielinización de axones nerviosos. - Google Patents

Derivados de estradiol sustituidos en 6 para uso en remielinización de axones nerviosos.

Info

Publication number
MX354409B
MX354409B MX2013010650A MX2013010650A MX354409B MX 354409 B MX354409 B MX 354409B MX 2013010650 A MX2013010650 A MX 2013010650A MX 2013010650 A MX2013010650 A MX 2013010650A MX 354409 B MX354409 B MX 354409B
Authority
MX
Mexico
Prior art keywords
remyelination
nerve axons
estradiol derivatives
substituted estradiol
substituted
Prior art date
Application number
MX2013010650A
Other languages
English (en)
Other versions
MX2013010650A (es
Inventor
G Yarger James
H Nye Steven
Original Assignee
Endece Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endece Llc filed Critical Endece Llc
Publication of MX2013010650A publication Critical patent/MX2013010650A/es
Publication of MX354409B publication Critical patent/MX354409B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Abstract

Se revela un método para remielinizar axones con un compuesto estradiol sustituido en 6 de la fórmula (ver Fórmula) El método se puede usar para tratar una variedad de enfermedades de desmielinización.
MX2013010650A 2011-03-21 2012-03-21 Derivados de estradiol sustituidos en 6 para uso en remielinización de axones nerviosos. MX354409B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161454873P 2011-03-21 2011-03-21
PCT/US2012/029973 WO2012129324A2 (en) 2011-03-21 2012-03-21 6-substituted estradiol derivatives for use in remyelination of nerve axons

Publications (2)

Publication Number Publication Date
MX2013010650A MX2013010650A (es) 2013-10-07
MX354409B true MX354409B (es) 2018-03-05

Family

ID=46877849

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013010650A MX354409B (es) 2011-03-21 2012-03-21 Derivados de estradiol sustituidos en 6 para uso en remielinización de axones nerviosos.

Country Status (13)

Country Link
US (2) US9364486B2 (es)
EP (1) EP2688570B1 (es)
JP (1) JP6174563B2 (es)
KR (1) KR102080151B1 (es)
CN (2) CN106420767A (es)
AU (1) AU2012230974B2 (es)
BR (1) BR112013024168A2 (es)
CA (1) CA2830515C (es)
DK (1) DK2688570T3 (es)
ES (1) ES2561536T3 (es)
MX (1) MX354409B (es)
SG (1) SG193380A1 (es)
WO (1) WO2012129324A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG193380A1 (en) * 2011-03-21 2013-10-30 Endece Llc 6-substituted estradiol derivatives for use in remyelination of nerve axons
US9315540B2 (en) 2012-10-22 2016-04-19 Intas Pharmaceuticals Ltd. Process for the preparation of fulvestrant
JP2017512769A (ja) * 2014-03-19 2017-05-25 エンディース エルエルシーＥｎｄｅｃｅ，Ｌｌｃ アルツハイマー病の治療のための６−置換エストラジオール誘導体

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136160A (en) * 1977-08-17 1979-01-23 Cohen Steven R Specific assay for active demyelinization
JPH0193529A (ja) * 1987-10-05 1989-04-12 Mect Corp シアロシルコレステロールの脱髄性疾患治療剤
JPH01193529A (ja) 1988-01-27 1989-08-03 Yoshitsugu Takano 液体循環装置
EP1931385B1 (en) * 2005-09-30 2018-02-28 Endece, LLC (s)-6-methyloxaalkyl exemestane compounds and related methods of use
US8168621B2 (en) * 2005-09-30 2012-05-01 Endece, Llc 6-substituted estradiol derivatives and methods of use
US10174070B2 (en) * 2005-09-30 2019-01-08 Endece Llc 6-substituted estradiol derivatives and methods of use
ES2604079T3 (es) * 2006-11-30 2017-03-02 Endece, Llc Derivados de 6-alcoxialquil estradiol y métodos de uso
AU2011302065B2 (en) 2010-09-14 2016-12-01 Endece, Llc 6-substituted demethyl-estradiol derivatives as ER-beta agonists
SG193380A1 (en) * 2011-03-21 2013-10-30 Endece Llc 6-substituted estradiol derivatives for use in remyelination of nerve axons

Also Published As

Publication number Publication date
CA2830515A1 (en) 2012-09-27
CA2830515C (en) 2015-09-15
EP2688570B1 (en) 2015-11-18
CN103501790A (zh) 2014-01-08
WO2012129324A9 (en) 2012-11-15
AU2012230974A1 (en) 2013-09-26
JP6174563B2 (ja) 2017-08-02
JP2014508807A (ja) 2014-04-10
WO2012129324A2 (en) 2012-09-27
ES2561536T3 (es) 2016-02-26
US20160279144A1 (en) 2016-09-29
EP2688570A2 (en) 2014-01-29
SG193380A1 (en) 2013-10-30
CN106420767A (zh) 2017-02-22
AU2012230974B2 (en) 2016-05-12
CN103501790B (zh) 2016-08-17
MX2013010650A (es) 2013-10-07
US9636348B2 (en) 2017-05-02
KR102080151B1 (ko) 2020-02-21
US20120245131A1 (en) 2012-09-27
KR20140074253A (ko) 2014-06-17
DK2688570T3 (en) 2015-12-21
EP2688570A4 (en) 2014-09-10
BR112013024168A2 (pt) 2017-07-11
US9364486B2 (en) 2016-06-14

Similar Documents

Publication Publication Date Title
EA030383B9 (ru) Бициклически замещённые урацилы, способы их получения, их применение, лекарственное средство и способ лечения с их применением
MX348470B (es) Pirimidinas anilladas sustituidas y uso de las mismas.
MX361653B (es) Procedimiento para la preparación de derivados del ácido biliar.
JO3091B1 (ar) مشتقات حمض 3- فنيل بروبيونيك متفرعة واستخداماتها
MX2015007916A (es) Peri-carbinoles.
TN2014000122A1 (en) 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases
MX2020005533A (es) Nuevo proceso para la preparacion de derivados de piperidinilo-azetidina e intermediarios de los mismos, en donde dichos compuestos son inhibidores de mek.
PH12014501258A1 (en) Pyrazolopyridine derivatives, preparation process therefor and therapeutic use thereof
WO2011123946A8 (en) Kinase inhibitors and method of treating cancer with same
IN2015DN01151A (es)
MX2017000330A (es) Derivado de piridona que tiene un grupo tetrahidropiranilmetilo.
MX2014011354A (es) Compuestos de piridopirimidina sustituida y su uso como inhibidores de tirosina cinasa 3 similar a fms.
NZ711343A (en) Sodium salt of (2s, 5r)-6-benzyloxy-7-oxo-1,6-diaza-bicyclo [3.2.1 ] octane-2-carboxylic acid and its preparation
MX340816B (es) Compuestos que inhiben el glioblastoma y su uso.
IN2014MN01469A (es)
BR112014014762A8 (pt) método para preparação de cisteína ou de um derivado desta usando uma nova o-fosferina sulfidrilase
MX354409B (es) Derivados de estradiol sustituidos en 6 para uso en remielinización de axones nerviosos.
GB201107985D0 (en) Process
NZ707773A (en) Methods of treating liver diseases
MX2013006658A (es) Métodos para producir y usar brasinoesteroides para promover el crecimiento, la reparación y mantenimiento del músculo esquelético y la piel.
TN2015000095A1 (en) Macrolide derivatives, preparation thereof and therapeutic use thereof
MX348841B (es) Derivados de pirimidooxazocina como inhibidores de mtor.
IN2014DN07498A (es)
UA80063U (ru) Способ борьбы c колорадским жуком на посадках картофеля
IN2012DE00262A (es)

Legal Events

Date Code Title Description
FG Grant or registration